I'll take an update on the re-engineering of the Ohm offering for auditing and compliance and if it has rolled out as a fully operational trial as yet?
If yes, is it meeting, exceeding expectations?
Status of reduction of costs for LifX manufacturing? How are the negotiations progressing?
Broad outline of the EU strategy/expectations for LifX?
- Forums
- ASX - By Stock
- BUD
- Q&A Session next week
Q&A Session next week, page-3
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BUD (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online